| abstract |
The subject of the invention is a pharmaceutical active principle consisting exclusively of the association of the acid (ls, 3r, 4r, 5r) -3 - {[(2e) -3- (3,4-dihydroxyphenyl) - 2-propenoyl] oxy} - 1,4,5-trihydroxycyclohexanecarboxylic and (2s, 3e, 4s) -4- {2- [2- (3,4-dihydroxyphenyl) ethoxy] -2-oxoethyl} -3-ethylidene Methyl -2- (pd-glucopyranosyloxy) -3,4-dihydro- 2h-pyrane-5-carboxylate for use as a medicament or veterinary product, in particular in the prevention and / or treatment of pathological disturbances of carbohydrate metabolism and / or lipid. |